Coagulation (also known as clotting) is the process by which blood changes from a liquid to a gel, forming a blood clot. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The mechanism of coagulation involves activation, adhesion, and aggregation of platelets along with deposition and maturation of fibrin. Disorders of coagulation are disease states which can result in bleeding (hemorrhage or bruising) or obstructive clotting (thrombosis).
Equipment
PMA offers state of the art fully automated Coagulation Analyzers from Behnk Elektronik (Germany)
Founded more than 30 years ago, this family-owned business has been successfully specializing in the development of automated solutions for the analysis of blood coagulation values. Behnk Elektronik Coagulation Analyzers employ two patented detection methods: an opto-mechanical system for plasma assays on clotting, chromogenic substrates and immunology, and a mechanical detection system for clotting tests with whole blood and plasma.
Reagent
PMA Offers complete portfolio of Coagulation Reagents from Technoclone (Austria).
Technoclone was founded in 1987 by Prof. Dr. Bernd Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibindâ) in the field of fibrinolysis.
Today, Technoclone is a world leading producer not only of ELISA systems but also of global and special coagulation tests, control and reference plasmas and protein and lipid diagnostics.
Technoclone high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies such as ROCHE